Menu
Join ACMG
Foundation
Donate
Sign In
Search
Clinical Resources
ACT Sheets
Genetics Laboratory Standards
ACMG Member Comment
Journals
Publications: Genetics in Medicine
Publications: Genetics in Medicine Open
Education and Events
Annual Meeting
Education
ACMG Genetics Academy
E3 Genomics Pathways Program
Upcoming Events
Policy and Advocacy
Advocacy
Medical Genetics Awareness Week
U.S. Congress
Letters and Statements
State Advocacy
State Policy Map
Policy Topics
Action Center
Membership
Join ACMG
Renew Your Membership
Student Interest Groups
Careers in Medical Genetics
Career Opportunities
Career Resource Center
NBSC
Newborn Screening Collaborative
About ACMG
History
Vision and Mission
Strategic Plan
Leadership & Staff
Committees
ClinGen
ACMG Newsroom
Omaveloxolone approved for patients aged 16 years and older with Friedreich ataxia (FRDA): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
